CIRC (01763) Subsidiary Releases New Isotope Separation Technology for Advanced Nuclear Medicine and Controlled Nuclear Fusion

Stock News
Oct 17

CIRC (01763) announced that its subsidiary, Chengdu Nuclear High Technology Isotope Co., Ltd. (Nuclear High Technology), has officially launched a new isotope separation technology based on the fourth-generation "MOF" materials called “Adsorption Catcher.” This innovation aims to inject new momentum into the fields of advanced nuclear medicine and controlled nuclear fusion, paving the way for new industrial development prospects. The “Adsorption Catcher” technology innovatively incorporates fourth-generation "MOF" materials, which were highlighted in the 2025 Nobel Prize in Chemistry, breaking through the inherent framework of traditional isotope separation technologies and achieving "customized design" of separation materials at the molecular scale. The “Adsorption Catcher” technology showcases significant advantages, including "high purity, high efficiency, low cost, and low energy consumption." It has a wide range of applications covering key areas crucial to the national economy, such as nuclear medicine, nuclear fusion, heavy water reactors, and biomedical research. This development will provide core technological support for building a "self-controllable, safe, and stable" isotope supply chain in China, helping to reduce reliance on imported high-end isotopes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10